Ultralife (NASDAQ:ULBI) Receives “Buy” Rating from Benchmark

Benchmark restated their buy rating on shares of Ultralife (NASDAQ:ULBI) in a research report report published on Friday morning,Benzinga reports. Benchmark currently has a $14.00 target price on the technology company’s stock.

Separately, StockNews.com downgraded shares of Ultralife from a “strong-buy” rating to a “buy” rating in a report on Thursday, October 3rd.

Ultralife Trading Down 4.0 %

Shares of ULBI stock opened at $7.36 on Friday. Ultralife has a 12-month low of $6.36 and a 12-month high of $13.39. The firm has a market cap of $122.40 million, a P/E ratio of 13.38 and a beta of 0.98. The company has a quick ratio of 2.06, a current ratio of 3.30 and a debt-to-equity ratio of 0.04. The company has a 50 day moving average of $8.97 and a 200-day moving average of $10.23.

Institutional Investors Weigh In On Ultralife

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. O Shaughnessy Asset Management LLC bought a new position in shares of Ultralife in the first quarter worth approximately $100,000. Barclays PLC grew its stake in Ultralife by 21.3% during the third quarter. Barclays PLC now owns 13,395 shares of the technology company’s stock valued at $121,000 after acquiring an additional 2,355 shares in the last quarter. Rhumbline Advisers grew its stake in Ultralife by 1,728.3% during the second quarter. Rhumbline Advisers now owns 11,811 shares of the technology company’s stock valued at $125,000 after acquiring an additional 11,165 shares in the last quarter. Perritt Capital Management Inc. lifted its position in Ultralife by 25.0% during the first quarter. Perritt Capital Management Inc. now owns 15,000 shares of the technology company’s stock valued at $132,000 after purchasing an additional 3,000 shares during the last quarter. Finally, Juncture Wealth Strategies LLC bought a new position in Ultralife during the third quarter valued at $165,000. Hedge funds and other institutional investors own 30.68% of the company’s stock.

Ultralife Company Profile

Ultralife Corporation, together with its subsidiaries, designs, manufactures, installs, and maintains power, and communication and electronics systems worldwide. The company operates in two segments, Battery & Energy Products and Communications Systems. The Battery & Energy Products segment offers lithium 9-volt, cylindrical, thin lithium manganese dioxide, rechargeable, and other non-rechargeable batteries; lithium-ion cells, multi-kilowatt module lithium-ion battery systems, and uninterruptable power supplies; and rugged military and commercial battery charging systems and accessories, including smart chargers, multi-bay charging systems, and various cables.